Loading profile

Loading sourced facts.

01 Finding sources

02 Reading evidence

03 Filing the card

LatchBio | Cold Start

Checked May 27 2026

LatchBio

LatchBio sells a cloud data and compute platform for biotech R&D teams that lets bench biologists run bioinformatics workflows without writing code or managing cloud infrastructure.

latch.bioChecked May 27 202632 cited sources

Source mix1 independent7 reported8 company16 data vendor

Raised$33.2MNot verified[23]

Last roundSeries A · $28MCorroborated[1]+1

FoundersKyle Giffin, Kenny Workman, Alfredo AndereNot verified[25]+4

HQSan Francisco, United StatesCorroborated[1]+2

Headcount26 · May 2026Not verified[18]+1

Founded2021Corroborated[2]+1

Evidence notes

Who uses it: Pharma and biotech R&D teams (300+ per company self-description), academic labs (free tier), and kit/assay/instrument providers who want to bundle analysis software with their hardware products.[1]+10Reported
Public signals: LatchBio 2026 Company Profile: Valuation, Funding & Investors[22]Not verified
Financing: Total raised is $33,200,000.[23]

Source ledger

[1]LatchBio Raises $28M Series A to Bring a Modern Data Analysis Stack to Biologists - BioSpaceIndependent analysis · biospace.com · May 27 2026
[2]Latch Bio Emerges from Stealth with Seed Funding Round Led by Lux Capital - BioSpaceIndependent report · biospace.com · May 27 2026
[3]LatchBio raises $28M to corral bio data - VentureBeatIndependent report · venturebeat.com · May 27 2026
[4]Meet LatchBio - MarkTechPostIndependent report · marktechpost.com · May 27 2026
[5]